OCTOBIDPublic Tender GazetteEarly-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
synopsis monitored from grants-gov.
- Buyer / agency
- National Institutes of Health
- Notice type
- synopsis
- Solicitation number
- RFA-CA-27-001
- Posted
- June 3, 2026
- Response deadline
- November 10, 2026
- Location
- US
- Estimated value
- $150,000 USD
- NAICS
- Not supplied
- Source
- grants-gov
Summary
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies offering new capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens for basic, clinical, or epidemiological cancer research. The NOFO solicits R61 applications for early-stage projects proposing proof-of-concept/pilot studies to test the techni…
See the official source link, all documents, and the full solicitation text — and prepare a proposal working draft with AI — with a free Octobid account.
Summaries are indexed from official public sources; the issuing platform’s notice, documents, and amendments always control.